» Authors » Emily See

Emily See

Explore the profile of Emily See including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 32
Citations 280
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Soranno D, Awdishu L, Bagshaw S, Basile D, Bell S, Bihorac A, et al.
Kidney Int . 2025 Jan; PMID: 39848406
Sex differences exist in acute kidney injury (AKI), and the role that sex and gender play along the AKI care continuum remains unclear. The 33rd Acute Disease Quality Initiative meeting...
2.
Ostermann M, Lumlertgul N, Jeong R, See E, Joannidis M, James M
Lancet . 2025 Jan; 405(10474):241-256. PMID: 39826969
Acute kidney injury (AKI) is a common, heterogeneous, multifactorial condition, which is part of the overarching syndrome of acute kidney diseases and disorders. This condition's incidence highest in low-income and...
3.
Preeprem N, See E, Namachivayam S, Gelbart B
Crit Care Resusc . 2025 Jan; 26(4):319-325. PMID: 39781487
Objective: Frusemide is a common diuretic administered to critically ill children intravenously, by either continuous infusion (CI) or intermittent bolus (IB). We aim to describe the characteristics of children who...
4.
Ransom J, See E, Eastwood G, Opdam H, Bellomo R, Jones D
Intern Med J . 2024 Oct; 54(12):1981-1989. PMID: 39425571
Background: Some patients experience early (within 48 h) clinical deterioration and medical emergency team (MET) review following intensive care unit (ICU) discharge. Few studies have explored early MET review, despite...
5.
Stanski N, Gist K, Hasson D, Stenson E, Seo J, Ollberding N, et al.
Crit Care Med . 2024 Sep; 52(11):1686-1699. PMID: 39258974
Objectives: Pediatric sepsis-associated acute kidney injury (AKI) often requires continuous renal replacement therapy (CRRT), but limited data exist regarding patient characteristics and outcomes. We aimed to describe these features, including...
6.
Htay H, Cho Y, Jha V, See E, Arruebo S, Caskey F, et al.
Nephrol Dial Transplant . 2024 Sep; 39(Supplement_2):ii11-ii17. PMID: 39235197
Background: Hemodialysis (HD) is the most commonly utilized modality for kidney replacement therapy worldwide. This study assesses the organizational structures, availability, accessibility, affordability and quality of HD care worldwide. Methods:...
7.
Spano S, Maeda A, Lam J, Chaba A, Phongphithakchai A, Pattamin N, et al.
Blood Purif . 2024 Sep; 53(11-12):928-936. PMID: 39222620
Introduction: Hypotension is common during intermittent hemodialysis (IHD) and may be due to a decreased cardiac index (CI). However, no study has simultaneously and continuously measured CI and mean arterial...
8.
See E, Ethier I, Cho Y, Htay H, Arruebo S, Caskey F, et al.
Kidney Int Rep . 2024 Aug; 9(8):2410-2419. PMID: 39156158
Introduction: Kidney failure treated with hemodialysis (HD), or peritoneal dialysis (PD) is a major global health problem that is associated with increased risks of death and hospitalization. This study aimed...
9.
Maeda A, Baldwin I, Spano S, Chaba A, Phongphithakchai A, Pattamin N, et al.
Blood Purif . 2024 Aug; 53(11-12):884-892. PMID: 39137744
Introduction: Hematocrit monitoring during continuous renal replacement therapy (CRRT) allows the continuous estimation of relative blood volume (RBV). This may enable early detection of intravascular volume depletion prior to clinical...
10.
Roberts M, Davies C, Brown L, Chua S, Irish G, Kairaitis L, et al.
Clin Kidney J . 2024 Jun; 17(5):sfae103. PMID: 38938326
Background: Worldwide, most people requiring kidney replacement therapy receive haemodialysis (HD) three times per week. Greater HD time and/or frequency may improve survival, but implementation requires understanding potential benefits across...